NO20074937A - Taurinsyntese, produksjon og anvendelse som legemiddel - Google Patents
Taurinsyntese, produksjon og anvendelse som legemiddelInfo
- Publication number
- NO20074937A NO20074937A NO20074937A NO20074937A NO20074937A NO 20074937 A NO20074937 A NO 20074937A NO 20074937 A NO20074937 A NO 20074937A NO 20074937 A NO20074937 A NO 20074937A NO 20074937 A NO20074937 A NO 20074937A
- Authority
- NO
- Norway
- Prior art keywords
- drug
- production
- taurine synthesis
- taurine
- synthesis
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/57—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
- C07C323/58—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton
- C07C323/59—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton with acylated amino groups bound to the carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/145—Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
- C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C309/13—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
- C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C309/13—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton
- C07C309/14—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton containing amino groups bound to the carbon skeleton
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Psychiatry (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EG2005010013 | 2005-01-05 | ||
| PCT/EG2005/000044 WO2006072259A2 (en) | 2005-01-05 | 2005-12-31 | Taurine synthesis, production and utility as a medicine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20074937A true NO20074937A (no) | 2007-09-28 |
Family
ID=36647837
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20074937A NO20074937A (no) | 2005-01-05 | 2007-09-28 | Taurinsyntese, produksjon og anvendelse som legemiddel |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP1844006A2 (pt) |
| JP (1) | JP2008526789A (pt) |
| KR (1) | KR20070091198A (pt) |
| CN (1) | CN101146767A (pt) |
| AP (1) | AP2007004084A0 (pt) |
| AU (1) | AU2005324199A1 (pt) |
| BR (1) | BRPI0519606A2 (pt) |
| CA (1) | CA2593563A1 (pt) |
| EA (1) | EA200701434A1 (pt) |
| IL (1) | IL184221A0 (pt) |
| MA (1) | MA29238B1 (pt) |
| MX (1) | MX2007008196A (pt) |
| NO (1) | NO20074937A (pt) |
| TN (1) | TNSN07226A1 (pt) |
| WO (1) | WO2006072259A2 (pt) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20100091219A (ko) | 2007-11-30 | 2010-08-18 | 더 리전트 오브 더 유니버시티 오브 캘리포니아 | 시스테아민 산물을 이용한 비-알코올성 지방성간염(ｎａｓｈ) 치료 방법 |
| CN103382170B (zh) * | 2012-10-25 | 2015-04-08 | 潜江永安药业股份有限公司 | 一种牛磺酸的制备方法 |
| CN106728405A (zh) * | 2016-11-15 | 2017-05-31 | 陈思文 | 一种牛磺酸和水溶性茶多酚复方组合物及其制备方法与应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS58140017A (ja) * | 1981-12-22 | 1983-08-19 | Junichi Azuma | 心不全治療剤 |
| JPH08208464A (ja) * | 1994-12-02 | 1996-08-13 | Taisho Pharmaceut Co Ltd | 高脂血症の治療及び予防薬 |
| US6184227B1 (en) * | 1995-07-21 | 2001-02-06 | Savvipharm Inc. | Salts of aminoimidazole carboxamide useful in the prevention and treatment of liver diseases |
| SE9601395D0 (sv) * | 1996-04-12 | 1996-04-12 | Dieter Haeussinger | New therapeutic treatment 1 |
| GB9722361D0 (en) * | 1997-10-24 | 1997-12-17 | Pharma Nord Uk Ltd | Pharmaceutical formulation for treating liver disorders |
| NZ527924A (en) * | 1999-01-29 | 2005-01-28 | Mars Uk Ltd | Antioxidant compositions and methods for companion animals |
| WO2001026642A2 (en) * | 1999-10-08 | 2001-04-19 | Joyce Corinne Bechthold | Methods and compositions for treating neurobehavioral disorders |
| CN1340502A (zh) * | 2000-06-30 | 2002-03-20 | 张永春 | 牛磺酸合锌的生产工艺 |
| CN1268733C (zh) * | 2004-07-20 | 2006-08-09 | 刘辉 | 牛磺酸功能啤酒及其生产工艺 |
-
2005
- 2005-12-31 CA CA002593563A patent/CA2593563A1/en not_active Abandoned
- 2005-12-31 KR KR1020077016443A patent/KR20070091198A/ko not_active Application Discontinuation
- 2005-12-31 EA EA200701434A patent/EA200701434A1/ru unknown
- 2005-12-31 BR BRPI0519606-0A patent/BRPI0519606A2/pt not_active IP Right Cessation
- 2005-12-31 AU AU2005324199A patent/AU2005324199A1/en not_active Abandoned
- 2005-12-31 JP JP2007549796A patent/JP2008526789A/ja active Pending
- 2005-12-31 CN CNA2005800460663A patent/CN101146767A/zh active Pending
- 2005-12-31 WO PCT/EG2005/000044 patent/WO2006072259A2/en active Application Filing
- 2005-12-31 MX MX2007008196A patent/MX2007008196A/es not_active Application Discontinuation
- 2005-12-31 AP AP2007004084A patent/AP2007004084A0/xx unknown
- 2005-12-31 EP EP05818935A patent/EP1844006A2/en not_active Withdrawn
-
2007
- 2007-06-14 TN TNP2007000226A patent/TNSN07226A1/fr unknown
- 2007-06-26 IL IL184221A patent/IL184221A0/en unknown
- 2007-07-26 MA MA30110A patent/MA29238B1/fr unknown
- 2007-09-28 NO NO20074937A patent/NO20074937A/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| TNSN07226A1 (en) | 2008-11-21 |
| MX2007008196A (es) | 2008-02-22 |
| JP2008526789A (ja) | 2008-07-24 |
| EP1844006A2 (en) | 2007-10-17 |
| CA2593563A1 (en) | 2006-07-13 |
| WO2006072259A2 (en) | 2006-07-13 |
| AP2007004084A0 (en) | 2007-08-31 |
| AU2005324199A1 (en) | 2006-07-13 |
| KR20070091198A (ko) | 2007-09-07 |
| EA200701434A1 (ru) | 2008-10-30 |
| WO2006072259A3 (en) | 2007-10-04 |
| MA29238B1 (fr) | 2008-02-01 |
| CN101146767A (zh) | 2008-03-19 |
| IL184221A0 (en) | 2008-12-29 |
| BRPI0519606A2 (pt) | 2009-02-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO2023047I1 (no) | Cedazuridine, or a pharmaceutically acceptable salt thereof | |
| DK2051975T3 (da) | Substituerede prolinamider, fremstilling deraf og anvendelse deraf som lægemiddel. | |
| DK1849470T4 (en) | Cancerlægemiddel, som indeholder alpha, alpha, alpha-trifluorthymidin og thymidin-phosphorylase-inhibitor | |
| NO2014028I1 (no) | Empagliflozin og salter derav, og spesielt Empagliflozin | |
| DK1948149T4 (da) | Formulering, som omfatter metformin og vildagliptin | |
| DK1954808T3 (da) | Enzympræparat, der giver en ren smag | |
| DK1902037T3 (da) | 2,4-diamino-pyrimidiner som auroainhibitorer | |
| DK1711494T3 (da) | Arylsubstituerede heterocykler, fremgangsmåde til deres fremstilling og deres anvendelse som lægemiddel | |
| DE602006007875D1 (de) | Kapseln | |
| SI1913001T1 (sl) | (r)-n-metilnaltrekson, postopki za njega sintezo in njega farmacevtsko uporabo | |
| DE602006013342D1 (de) | Druck-verriegelung | |
| DE602005022897D1 (de) | Piperidinylamino-thienoä2,3-dü-pyrimidinverbindungen | |
| DK1957073T3 (da) | Lægemiddel | |
| DK2338606T3 (da) | Sprinklerenhed | |
| DK1787519T3 (da) | Skoldeapparat | |
| DK2364975T3 (da) | Nyt amidderivat og anvendelse deraf som medikament. | |
| FI20055364A0 (fi) | Aikasynkronointi | |
| DE602006014973D1 (de) | Neuartige cercosporamidderivate | |
| DK1816121T3 (da) | 9-chlor-15-deoxyprostaglandinderivater, fremgangsmåde til deres fremstilling og deres anvendelse som medikamenter | |
| DK1954288T3 (da) | Amidin-derivater og anvendelse deraf som lægemiddel | |
| NO20074937A (no) | Taurinsyntese, produksjon og anvendelse som legemiddel | |
| DK1899321T3 (da) | Heteroarylsubstituerede amider, der omfatter en mættet linkergruppe, og anvendelse deraf som lægemidler | |
| ZA200710146B (en) | New thiazolidinones without basic nitrogen, their production and use as pharmaceutical agents | |
| DK2240487T3 (da) | Triazolopyridaziner som para-inhibitorer, fremstilling og anvendelse heraf som lægemiddel | |
| DK1720557T3 (da) | Hurtig-opløselig, smagsmaskeret tablet |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |